- CA$218.41m
- CA$263.06m
- CA$186.92m
- 56
- 86
- 53
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 98.6 | 64 | 115 | 200 | 187 |
Cost of Revenue | |||||
Gross Profit | 46.7 | 22.7 | 62.5 | 121 | 88.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 106 | 119 | 5.86 | 131 | 161 |
Operating Profit | -7.51 | -54.5 | 109 | 69 | 25.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -19.1 | -57.6 | 99.1 | 61 | 20 |
Provision for Income Taxes | |||||
Net Income After Taxes | -31.4 | -56.6 | 99.1 | 155 | 15.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -31.4 | -56.6 | 99.1 | 155 | 15.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -31.4 | -56.6 | 99.1 | 155 | 15.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.75 | -0.942 | 0.289 | 2.65 | 0.213 |